BGI Genomics Co., Ltd. (SHE:300676)
48.37
+0.90 (1.90%)
Jan 8, 2026, 12:34 PM CST
BGI Genomics Market Cap
BGI Genomics has a market cap or net worth of 18.22 billion as of January 7, 2026. Its market cap has increased by 0.57% in one year.
Market Cap
18.22B
Enterprise Value
15.32B
Revenue
3.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
48.37
Market Cap Chart
Since July 14, 2017, BGI Genomics's market cap has increased from 7.86B to 18.22B, an increase of 131.88%. That is a compound annual growth rate of 10.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 18.22B | 4.65% |
| Dec 31, 2025 | 17.41B | 8.78% |
| Dec 31, 2024 | 16.01B | -18.66% |
| Dec 29, 2023 | 19.68B | -7.14% |
| Dec 30, 2022 | 21.19B | -41.13% |
| Dec 31, 2021 | 35.99B | -29.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 418.97B |
| WuXi AppTec | 267.64B |
| Shenzhen Mindray Bio-Medical Electronics | 241.39B |
| Sichuan Biokin Pharmaceutical | 133.70B |
| Aier Eye Hospital Group | 103.93B |
| Shanghai United Imaging Healthcare | 102.91B |
| Zhangzhou Pientzehuang Pharmaceutical., | 102.74B |
| Yunnan Baiyao Group Co.,Ltd | 101.27B |